Screener
ANI Pharmaceuticals ANIP Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
The Company is authorized to issue up to 66.0 million shares of common stock with a par value of $0.0001 per share, 0.8 million shares of class C special stock with a par value of $0.0001 per share, and 1.7 million shares of undesignated preferred stock with a par value of $0.0001 per share at June 30, 2026.
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's preferred stock, shares authorized?
- ANI Pharmaceuticals (ANIP) reported preferred stock, shares authorized of $1.7M in Q2 2026.
- How has ANI Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- ANI Pharmaceuticals's preferred stock, shares authorized increased by 2.0% year-over-year, from $1.67M to $1.7M.
- What is the long-term trend for ANI Pharmaceuticals's preferred stock, shares authorized?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $1.67M to $1.67M.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about ANI Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude